BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
European Commission at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
European Commission takes part in 3 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on EU medicines policy, from regulatory incentives and market exclusivity to the route to regulatory acceptance for new approach methodologies that model human biology. It also joins the European Investment Bank to ask how Europe can scale innovation in women's health.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
European Commission Brussels, Belgium | |
Executive body of the European Union, proposing legislation and running EU programmes, including health, medicines and research policy. | Panel Tue Nov 10 09:00–09:45 Accelerating Innovation and Market Exclusivity Through Regulatory Incentives How updated EU drug laws and the Biotech Act change how long new medicines are shielded from competing copies, compared with rules elsewhere. Panel Tue Nov 10 14:30–14:55 Investing in Women’s Health: How Can Europe Scale Innovation? How Europe can grow investment in women's health, previewing a European Investment Bank study of the field's research, unmet needs and funding options. Panel Wed Nov 11 09:00–09:45 From NAMs (New Approach Methodologies) Innovation to Regulatory acceptance: Accelerating human-relevant modelling How lab models built on human biology, from organs-on-chips to AI computer models, can speed drug development and win regulators' acceptance. |
Find decision makers at European Commission
Tell us what you sell and we’ll find the people at European Commission most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction